Cargando…
Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus
Ebola virus is the causative agent of Ebola virus disease in humans. The lethality of Ebola virus infection is about 50%, supporting the urgent need to develop anti-Ebola drugs. Glycoprotein (GP) is the only surface protein of the Ebola virus, which is functionally critical for the virus to attach a...
Autores principales: | Cui, Qinghua, Cheng, Han, Xiong, Rui, Zhang, Gang, Du, Ruikun, Anantpadma, Manu, Davey, Robert A., Rong, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315506/ https://www.ncbi.nlm.nih.gov/pubmed/30513600 http://dx.doi.org/10.3390/v10120678 |
Ejemplares similares
-
Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor
por: Cui, Qinghua, et al.
Publicado: (2018) -
Small Molecule Inhibitors of Influenza Virus Entry
por: Chen, Zhaoyu, et al.
Publicado: (2021) -
Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry
por: Du, Ruikun, et al.
Publicado: (2019) -
Evaluation of Phenol-Substituted Diphyllin Derivatives
as Selective Antagonists for
Ebola Virus Entry
por: Plescia, Caroline B., et al.
Publicado: (2022) -
SARS-CoV-2 cell entry and targeted antiviral development
por: Chen, Zinuo, et al.
Publicado: (2021)